SCM
Sio Capital Management Portfolio holdings
AUM
$249M
This Quarter Return
-4.38%
1 Year Return
+117.71%
3 Year Return
+238.99%
5 Year Return
+411.91%
10 Year Return
+912.87%
AUM
$234M
AUM Growth
+$234M
(-7.6%)
Cap. Flow
-$14.7M
Cap. Flow
% of AUM
-6.26%
Top 10 Holdings %
Top 10 Hldgs %
74.74%
Holding
68
New
4
Increased
6
Reduced
6
Closed
20
Top Buys
| 1 |
GSK
GSK
|
$23.3M |
| 2 |
Sanofi
SNY
|
$13.6M |
| 3 |
Cencora
COR
|
$13.4M |
| 4 |
Smith & Nephew
SNN
|
$5.3M |
| 5 |
The Beauty Health Co
SKIN
|
$3.5M |
Top Sells
| 1 |
HCA Healthcare
HCA
|
$10.4M |
| 2 |
Biogen
BIIB
|
$7.32M |
| 3 |
Medtronic
MDT
|
$7.18M |
| 4 |
Sight Sciences
SGHT
|
$6.52M |
| 5 |
NTUS
Natus Medical Inc
NTUS
|
$6.26M |
Sector Composition
| 1 | Healthcare | 85.76% |
| 2 | Financials | 9.81% |
| 3 | Consumer Staples | 3.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Cencora
COR
$56.5B
| $38.2M | 12.14% | 282,399 +99,065 | +54% | +$13.4M |
|
|
2
GSK
GSK
$79.9B
| $23.3M | 7.39% | +790,600 | New | +$23.3M |
|
|
MSAC
3
DELISTED
Medicus Sciences Acquisition Corp. Class A Ordinary Share
MSAC
| $23M | 7.31% | 2,323,000 | – | – |
|
|
BCYC
4
Bicycle Therapeutics
BCYC
$511M
| $15.9M | 5.05% | 683,425 -5,564 | -0.8% | -$129K |
|
5
Organon & Co
OGN
$2.45B
| $14.7M | 4.68% | 628,836 +53,981 | +9% | +$1.26M |
|
6
Cigna
CI
$80.3B
| $14.6M | 4.64% | 52,611 -423 | -0.8% | -$117K |
|
|
7
Sanofi
SNY
$121B
| $13.6M | 4.31% | +356,888 | New | +$13.6M |
|
8
Inogen
INGN
$216M
| $12.7M | 4.02% | 521,295 -4,143 | -0.8% | -$101K |
|
9
Centene
CNC
$14.3B
| $9.88M | 3.14% | 127,011 -2,000 | -2% | -$156K |
|
10
United Therapeutics
UTHR
$13.8B
| $9.41M | 2.99% | 44,959 +5,000 | +13% | +$1.05M |
|
|
11
The Beauty Health Co
SKIN
$264M
| $7.77M | 2.47% | 658,964 +296,670 | +82% | +$3.5M |
|
|
12
Smith & Nephew
SNN
$16.3B
| $5.3M | 1.69% | +228,390 | New | +$5.3M |
|
13
Vanda Pharmaceuticals
VNDA
$279M
| $4.83M | 1.54% | 488,965 | – | – |
|
|
PNT
14
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
| $4.21M | 1.34% | 544,545 +40,000 | +8% | +$309K |
|
|
NARI
15
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $4.17M | 1.33% | 57,466 -55,000 | -49% | -$3.99M |
|
16
Universal Health Services
UHS
$11.6B
| $3.59M | 1.14% | 40,725 | – | – |
|
|
EUCRU
17
DELISTED
Eucrates Biomedical Acquisition Corp. Unit
EUCRU
| $2.49M | 0.79% | 248,674 | – | – |
|
18
Orchestra BioMed
OBIO
$147M
| $2.48M | 0.79% | 250,000 | – | – |
|
19
Spyre Therapeutics
SYRE
$996M
| $2.46M | 0.78% | 4,668,536 | – | – |
|
20
X4 Pharmaceuticals
XFOR
$84.2M
| $2.43M | 0.77% | 1,418,461 +1,141,552 | +412% | +$1.95M |
|
21
Modular Medical
MODD
$39.9M
| $2.37M | 0.75% | 574,352 | – | – |
|
|
CBAY
22
DELISTED
Cymabay Therapeutics
CBAY
| $1.95M | 0.62% | 555,610 | – | – |
|
|
RCOR
23
DELISTED
Renovacor, Inc.
RCOR
| $1.85M | 0.59% | 735,908 | – | – |
|
24
Merus
MRUS
$4.98B
| $1.76M | 0.56% | 87,953 | – | – |
|
|
AFMD
25
DELISTED
Affimed
AFMD
| $1.69M | 0.54% | 821,065 | – | – |
|